337 related articles for article (PubMed ID: 27599637)
21. LANA-Mediated Recruitment of Host Polycomb Repressive Complexes onto the KSHV Genome during De Novo Infection.
Toth Z; Papp B; Brulois K; Choi YJ; Gao SJ; Jung JU
PLoS Pathog; 2016 Sep; 12(9):e1005878. PubMed ID: 27606464
[TBL] [Abstract][Full Text] [Related]
22. Latency-associated nuclear antigen (LANA) of Kaposi's sarcoma-associated herpesvirus interacts with origin recognition complexes at the LANA binding sequence within the terminal repeats.
Verma SC; Choudhuri T; Kaul R; Robertson ES
J Virol; 2006 Mar; 80(5):2243-56. PubMed ID: 16474132
[TBL] [Abstract][Full Text] [Related]
23. Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen modulates K1 expression through its cis-acting elements within the terminal repeats.
Verma SC; Lan K; Choudhuri T; Robertson ES
J Virol; 2006 Apr; 80(7):3445-58. PubMed ID: 16537612
[TBL] [Abstract][Full Text] [Related]
24. Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus recruits uracil DNA glycosylase 2 at the terminal repeats and is important for latent persistence of the virus.
Verma SC; Bajaj BG; Cai Q; Si H; Seelhammer T; Robertson ES
J Virol; 2006 Nov; 80(22):11178-90. PubMed ID: 16928741
[TBL] [Abstract][Full Text] [Related]
25. Bub1 and CENP-F can contribute to Kaposi's sarcoma-associated herpesvirus genome persistence by targeting LANA to kinetochores.
Xiao B; Verma SC; Cai Q; Kaul R; Lu J; Saha A; Robertson ES
J Virol; 2010 Oct; 84(19):9718-32. PubMed ID: 20660191
[TBL] [Abstract][Full Text] [Related]
26. Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen inhibits lytic replication by targeting Rta: a potential mechanism for virus-mediated control of latency.
Lan K; Kuppers DA; Verma SC; Robertson ES
J Virol; 2004 Jun; 78(12):6585-94. PubMed ID: 15163750
[TBL] [Abstract][Full Text] [Related]
27. LANA oligomeric architecture is essential for KSHV nuclear body formation and viral genome maintenance during latency.
De Leo A; Deng Z; Vladimirova O; Chen HS; Dheekollu J; Calderon A; Myers KA; Hayden J; Keeney F; Kaufer BB; Yuan Y; Robertson E; Lieberman PM
PLoS Pathog; 2019 Jan; 15(1):e1007489. PubMed ID: 30682185
[TBL] [Abstract][Full Text] [Related]
28. NDRG1 facilitates the replication and persistence of Kaposi's sarcoma-associated herpesvirus by interacting with the DNA polymerase clamp PCNA.
Zhang F; Liang D; Lin X; Zou Z; Sun R; Wang X; Liang X; Kaye KM; Lan K
PLoS Pathog; 2019 Feb; 15(2):e1007628. PubMed ID: 30811506
[TBL] [Abstract][Full Text] [Related]
29. Kaposi's sarcoma-associated herpesvirus (KSHV) latency-associated nuclear antigen regulates the KSHV epigenome by association with the histone demethylase KDM3A.
Kim KY; Huerta SB; Izumiya C; Wang DH; Martinez A; Shevchenko B; Kung HJ; Campbell M; Izumiya Y
J Virol; 2013 Jun; 87(12):6782-93. PubMed ID: 23576503
[TBL] [Abstract][Full Text] [Related]
30. A novel KRAB-Zinc finger protein interacts with latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus and activates transcription via terminal repeat sequences.
Watanabe A; Higuchi M; Fukushi M; Ohsawa T; Takahashi M; Oie M; Fujii M
Virus Genes; 2007 Apr; 34(2):127-36. PubMed ID: 17143723
[TBL] [Abstract][Full Text] [Related]
31. Accumulation of LANA at nuclear matrix fraction is important for Kaposi's sarcoma-associated herpesvirus replication in latency.
Ohsaki E; Suzuki T; Karayama M; Ueda K
Virus Res; 2009 Jan; 139(1):74-84. PubMed ID: 19027806
[TBL] [Abstract][Full Text] [Related]
32. The nucleosomal surface as a docking station for Kaposi's sarcoma herpesvirus LANA.
Barbera AJ; Chodaparambil JV; Kelley-Clarke B; Joukov V; Walter JC; Luger K; Kaye KM
Science; 2006 Feb; 311(5762):856-61. PubMed ID: 16469929
[TBL] [Abstract][Full Text] [Related]
33. LANA and hnRNP A1 Regulate the Translation of LANA mRNA through G-Quadruplexes.
Dabral P; Babu J; Zareie A; Verma SC
J Virol; 2020 Jan; 94(3):. PubMed ID: 31723020
[TBL] [Abstract][Full Text] [Related]
34.
Pires de Miranda M; Quendera AP; McVey CE; Kaye KM; Simas JP
J Virol; 2018 Nov; 92(21):. PubMed ID: 30111565
[TBL] [Abstract][Full Text] [Related]
35. The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus interacts preferentially with the terminal repeats of the genome in vivo and this complex is sufficient for episomal DNA replication.
Fejér G; Medveczky MM; Horvath E; Lane B; Chang Y; Medveczky PG
J Gen Virol; 2003 Jun; 84(Pt 6):1451-1462. PubMed ID: 12771414
[TBL] [Abstract][Full Text] [Related]
36. The 3D structure of Kaposi sarcoma herpesvirus LANA C-terminal domain bound to DNA.
Hellert J; Weidner-Glunde M; Krausze J; Lünsdorf H; Ritter C; Schulz TF; Lührs T
Proc Natl Acad Sci U S A; 2015 May; 112(21):6694-9. PubMed ID: 25947153
[TBL] [Abstract][Full Text] [Related]
37. The minimal replicator element of the Kaposi's sarcoma-associated herpesvirus terminal repeat supports replication in a semiconservative and cell-cycle-dependent manner.
Verma SC; Choudhuri T; Robertson ES
J Virol; 2007 Apr; 81(7):3402-13. PubMed ID: 17151118
[TBL] [Abstract][Full Text] [Related]
38. Poly(ADP-ribose) polymerase 1 binds to Kaposi's sarcoma-associated herpesvirus (KSHV) terminal repeat sequence and modulates KSHV replication in latency.
Ohsaki E; Ueda K; Sakakibara S; Do E; Yada K; Yamanishi K
J Virol; 2004 Sep; 78(18):9936-46. PubMed ID: 15331727
[TBL] [Abstract][Full Text] [Related]
39. KSHV genome harbors both constitutive and lytically induced enhancers.
Roy Chowdhury N; Gurevich V; Shamay M
J Virol; 2024 Jun; 98(6):e0017924. PubMed ID: 38695538
[TBL] [Abstract][Full Text] [Related]
40. Single molecule analysis of replicated DNA reveals the usage of multiple KSHV genome regions for latent replication.
Verma SC; Lu J; Cai Q; Kosiyatrakul S; McDowell ME; Schildkraut CL; Robertson ES
PLoS Pathog; 2011 Nov; 7(11):e1002365. PubMed ID: 22072974
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]